Hemianopsia, Homonymous study: Biofeedback training
Official title Biofeedback for Hemianopia Vision Rehabilitation
ClinicalTrials.gov ID: NCT05397873
What this study is testing
- What it's testing
- This study aims to see if a specific type of eye training called biofeedback helps people with vision loss on one side of their field of view.
- Who it's for
- The study is looking for people who have lost vision on one side of their field of view due to a stroke, brain tumor, or head injury.
- What's involved
- Participants will use a special eye-tracking device to practice moving their eyes toward their blind side. This helps them learn to see better in that area.
- Time commitment
- The source text does not specify the total duration or the number of visits required.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 90
You may be able to join if
- hemianopia cases previously diagnosed accordingly by microperimetry and other tests as needed
- 18-90 years old
- ability to follow the visual and auditory stimuli and training instructions
You likely can't join if
- previous or current treatment for low vision rehabilitation
- ocular diseases
- other serious clinical conditions not related to the hemianopia physiopathology
- both eyes with media opacity that impairs microperimetry testing
- lack of ability to perform the tests and training
The study team makes the final eligibility decision.
Where it is enrolling
- Toronto, Ontario, Canada
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 90 years. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Toronto, Ontario, Canada. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.